THERAPEUTIC PLATFORM
Overview
As a result of its recent merger with Intradigm Corporation, Silence now possesses one of the most comprehensive platforms in RNAi therapeutic development.
The company holds a powerful and strategic position in each of the three areas believed to be critical to building, protecting and commercializing RNAi therapeutics:
